Publications

Found 46 results
Author [ Title(Desc)] Year
Filters: First Letter Of Last Name is W  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
CDR-H3 diversity is not required for antigen recognition by synthetic antibodies, Persson, H., Ye W., Wernimont A., Adams J. J., Koide A., Koide S., Lam R., and Sidhu S. S. , J Mol Biol, Volume 425, Number 4, p.803-11, (2013)
Cell biology. New tricks for an old dimer, Wells, J. A., and Kossiakoff A. A. , Science, Volume 344, Number 6185, p.703-4, (2014)
Comparative proteomics of a model MCF10A-KRasG12V cell line reveals a distinct molecular signature of the KRasG12V cell surface., Ye, Xiaoying, Chan King C., Waters Andrew M., Bess Matthew, Harned Adam, Wei Bih-Rong, Loncarek Jadranka, Luke Brian T., Orsburn Benjamin C., Hollinger Bradley D., et al. , Oncotarget, 2016 Dec 27, Volume 7, Issue 52, p.86948-86971, (2016)
Comparative proteomics of a model MCF10A-KRasG12V cell line reveals a distinct molecular signature of the KRasG12V cell surface., Ye, Xiaoying, Chan King C., Waters Andrew M., Bess Matthew, Harned Adam, Wei Bih-Rong, Loncarek Jadranka, Luke Brian T., Orsburn Benjamin C., Hollinger Bradley D., et al. , Oncotarget, 2016 Dec 27, Volume 7, Issue 52, p.86948-86971, (2016)
Comparative proteomics of a model MCF10A-KRasG12V cell line reveals a distinct molecular signature of the KRasG12V cell surface., Ye, Xiaoying, Chan King C., Waters Andrew M., Bess Matthew, Harned Adam, Wei Bih-Rong, Loncarek Jadranka, Luke Brian T., Orsburn Benjamin C., Hollinger Bradley D., et al. , Oncotarget, 2016 Dec 27, Volume 7, Issue 52, p.86948-86971, (2016)
Comparative proteomics of a model MCF10A-KRasG12V cell line reveals a distinct molecular signature of the KRasG12V cell surface., Ye, Xiaoying, Chan King C., Waters Andrew M., Bess Matthew, Harned Adam, Wei Bih-Rong, Loncarek Jadranka, Luke Brian T., Orsburn Benjamin C., Hollinger Bradley D., et al. , Oncotarget, 2016 Dec 27, Volume 7, Issue 52, p.86948-86971, (2016)

Pages

University of Toronto  UCSF  The University of Chicago  QB3  Chicago Biomedical Consortium